Scientific Publications & Presentations

Banerji et al_Long-Term Efficacy And Safety Of Donidalorsen Taken Once Every 8 Weeks 2-Year Results From OASISplus.pdf Craig et al_Switching From Prior Long-Term Prophylactic Treatments To Donidalorsen For Hereditary Angioedema 2-Year Results From OASISplus.pdf Cohn et al_Donidalorsen For Long-Term Management Of Hereditary Angioedema 2-Year Results From The OASISplus Open-Label Extension Cohort.pdf

Waldman et al - Design of a Pivotal Trial Evaluating the Safety Tolerability and Efficacy of Zilganersen an investigational RNA-Targeted Antisense Therapy in People Living With Alexander Disease.pdf

Khatri et al - Efficacy and Safety of Donidalorsen in Adolescent Patients With Hereditary Angioedema.pdf Jacobs et al - Efficacy and Safeety of Donidalorsen in Adolescent Patients With Hereditary Angioedema - A Subanalysis of the Phase 3 OASIS-HAE Study.pdf